Articles From: Gluskin Sheff + Associates Inc. Announces Second Quarter Fiscal 2014 Results and Conference Call to GM 'Closest It Has Ever Been' to Reinstating Dividend--Update


2014/1/14
Gluskin Sheff + Associates Inc. Announces Second Quarter Fiscal 2014 Results and Conference Call Canada NewsWire TORONTO , Jan.
Sign-up for Gluskin Sheff + Associates Inc. Announces Second Quarter Fiscal 2014 Results and Conference Call investment picks
2014/4/4
Gluskin Sheff + Associates Inc. Announces Third Quarter Fiscal 2014 Results and Conference Call Canada NewsWire TORONTO , April 4, 2014 /CNW/ - Gluskin Sheff + Associates Inc. (the "Company") will issue its financial results for the three months ended March 31, 2014 on Friday, May 2, 2014.
Sign-up for Gluskin Sheff + Associates Inc. Announces Third Quarter Fiscal 2014 Results and Conference Call investment picks
Gluskin Sheff + Associates Inc. Declares Regular Quarterly Dividend of $0.1750, Special Dividend of $1.40, and Increase in Regular Quarterly Dividend Canada NewsWire TORONTO , Sept.
Sign-up for Gluskin Sheff + Associates Inc. Declares Regular Quarterly Dividend of $0.1750, Special Dividend of $1.40, and Increase in Regular Quarterly Dividend investment picks
2013/11/7
Gluskin Sheff + Associates Inc. Declares Regular Quarterly Dividend of $0.20 Canada NewsWire TORONTO , Nov.
Sign-up for Gluskin Sheff + Associates Inc. Declares Regular Quarterly Dividend of $0.20 investment picks
2014/2/6
Gluskin Sheff + Associates Inc. declares regular quarterly dividend of $0.20 and special dividend of $1.40 and announces normal course issuer bid Canada NewsWire TORONTO , Feb.
Sign-up for Gluskin Sheff + Associates Inc. declares regular quarterly dividend of $0.20 and special dividend of $1.40 and announces normal course issuer bid investment picks
2013/10/28
Red Hat, Inc. (NYSE: RHT), the world’s leading provider of open source solutions, announced today that it has contributed software to the Gluster Community that integrates the GlusterFS open software-defined storage filesystem with the Intel® Distribution for Apache Hadoop* software (Intel® Distribution). The resulting code, the Apache Hadoop Enablement on GlusterFS plugin, delivers a big data analytics solution that easily integrates with existing IT infrastructure.
Sign-up for Gluster Community Delivers Big Data Solution to Advance Enterprise Analytics investment picks
2014/1/23
NEW OXFORD, Pa.
Sign-up for Gluten-Free Growth Projected for 2014 investment picks
Gluten-free spirits are garnering headline-making press, and combined with the award-winning RWB Ultra-Premium Handcrafted Gluten-Free Vodka, the Aristocrat Group Corp.
Sign-up for Gluten-Free Spirits Becoming Mainstream investment picks
2014/2/6
Trusted Gluten Free Partner Establishes Team of Lifestyle Experts to Help Guide People through the Many Facets of Everyday Gluten Free Living BOULDER, Colo.
Sign-up for Glutino Introduces The Glutino Gluten Free Gurus investment picks
2014/2/13
GLV Group announces its third quarter results Canada NewsWire Highlights - Fiscal 2014 Q3 compared with Fiscal 2013 Q3 Revenues of $158.6 million , up 9.0%; Normalized adjusted EBITDA of $5.1 million , up 11.3%; Goodwill and intangible asset impairment charge of $26.9 million ; Net loss attributable to shareholders of GLV Inc. of $26.7 million or $0.61 per share, basic and diluted; Normalized net earnings of $1.5 million or $0.03 per share, basic and diluted; Large $28.0 million contract for Ovivo in the Municipal North America market; Backlog of $429.1 million , up 9.5% from the September 30, 2013 level; Net debt of $31.2 million , down 14.8% from the September 30, 2013 level.
Sign-up for GLV Group announces its third quarter results investment picks
GLV Group announces promising results for the second quarter of fiscal 2014 while continuing to implement its strategy Canada NewsWire MONTREAL , Nov.
Sign-up for GLV Group announces promising results for the second quarter of fiscal 2014 while continuing to implement its strategy investment picks
GLV Inc. invites its shareholders, members of the financial community and the media to its Annual General Meeting of Shareholders Canada NewsWire   MONTREAL , Sept.
Sign-up for GLV Inc. invites its shareholders, members of the financial community and the media to its Annual General Meeting of Shareholders investment picks
GLV Inc. reports on voting results associated to the election of directors at its Annual Meeting of Shareholders Canada NewsWire MONTREAL , Sept.
Sign-up for GLV Inc. reports on voting results associated to the election of directors at its Annual Meeting of Shareholders investment picks
2013/10/22
GLV Will Release Its Fiscal 2014 Second Quarter Results on November 7th, 2013 Canada NewsWire Invitation to the Conference Call MONTREAL , Oct.
Sign-up for GLV Will Release Its Fiscal 2014 Second Quarter Results on November 7th, 2013 investment picks
2014/1/15
GLV Will Release Its Fiscal 2014 Third Quarter Results on February 13th, 2014 Canada NewsWire Invitation to the Conference Call MONTREAL , Jan.
Sign-up for GLV Will Release Its Fiscal 2014 Third Quarter Results on February 13th, 2014 investment picks
2014/1/15
GlycoMimetics, Inc. (NASDAQ: GLYC) today announced the closing of its initial public offering of 8,050,000 shares of its common stock at an initial public offering price of $8.00 per share, which includes the exercise in full by the underwriters of their option to purchase up to 1,050,000 additional shares of common stock.
Sign-up for GlycoMimetics Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares investment picks
2013/9/13
GlycoMimetics, Inc. announced today that the European Medicines Agency (EMA) has granted orphan drug designation for GMI-1070 (rivipansel sodium) for the treatment of vaso-occlusive crisis (VOC) in patients with sickle cell disease.
Sign-up for GlycoMimetics Announces EMA’s Granting of Orphan Drug Status in European Union for GMI-1070 in Sickle Cell Disease investment picks
2014/3/14
GlycoMimetics, Inc. (NASDAQ: GLYC) reported today with great sorrow the sudden passing of William “Bill” Gust, who had served as a director of the company since 2006 and as a member of the audit committee of the Company’s board of directors.
Sign-up for GlycoMimetics Announces Sudden Passing of Board Director and Audit Committee Member William Gust investment picks
2014/4/1
GlycoMimetics, Inc. (NASDAQ: GLYC) announced today the addition of Timothy Pearson to its Board of Directors.
Sign-up for GlycoMimetics Appoints Tim Pearson to Board of Directors and as Audit Committee Chair investment picks
2014/4/9
GlycoMimetics, Inc. (NASDAQ:GLYC) announced today that three posters of preclinical research study data for its E-Selectin antagonist ( GMI-1271 ) were highlighted at the American Association for Cancer Research (AACR) Annual Meeting 2014 .
Sign-up for GlycoMimetics Presents Data on Its E-Selectin Antagonist at American Association for Cancer Research Annual Meeting 2014 investment picks
2014/3/31
GlycoMimetics, Inc. (NASDAQ: GLYC) today reported financial results for the fourth quarter and year ended December 31, 2013.
Sign-up for GlycoMimetics Reports Fourth Quarter and Year-End 2013 Results investment picks
2014/3/10
GlycoMimetics, Inc. (NASDAQ: GLYC) today announced that Rachel King, Chief Executive Officer, will present an overview of the company at the Barclays Capital 2014 Global Healthcare Conference on March 13, 2014, at 9:30 a.m. Eastern Time.
Sign-up for GlycoMimetics to Present at Barclays Global Healthcare Conference investment picks
2014/2/3
GlycoMimetics, Inc. (NASDAQ: GLYC) today announced that Rachel King, Chief Executive Officer, will be presenting at the 16th Annual BIO CEO & Investor Conference on Tuesday, February 11, 2014 at 1:30 p.m. Eastern Time.
Sign-up for GlycoMimetics to Present at BIO CEO & Investor Conference investment picks
2014/3/5
GlycoMimetics, Inc. (NASDAQ:GLYC) announced today plans to present findings from research studies of its E-Selectin antagonist ( GMI-1271 ) with three posters at the American Association for Cancer Research (AACR) Annual Meeting 2014 .
Sign-up for GlycoMimetics to Present GMI-1271 Research Findings at AACR Annual Meeting 2014 investment picks
2014/4/10
ADVISORY, April 10, 2014 (GLOBE NEWSWIRE) -- What: GlycoMimetics, Inc. [GLYC], a clinical stage biotechnology company focused on the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in which carbohydrate biology plays a key role, will visit the NASDAQ MarketSite in Times Square.
Sign-up for GlycoMimetics, Inc. [GLYC] to Ring The NASDAQ Stock Market Closing Bell investment picks
PHOENIX, Aug.
Sign-up for GlyEco Provides Glycol Recycling Services to Waste Management investment picks
General Motors Co.
Sign-up for GM 'Closest It Has Ever Been' to Reinstating Dividend investment picks
2014/1/12
By Jeff Bennett General Motors Co.
Sign-up for GM 'Closest It Has Ever Been' to Reinstating Dividend--Update investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: Gluskin Sheff + Associates Inc. Announces Second Quarter Fiscal 2014 Results and Conference Call to GM 'Closest It Has Ever Been' to Reinstating Dividend--Update
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity